Rani Therapeutics Holdings Inc - Ordinary Shares Class A
RANI
Get informed when a big investor buys or sells
+ FollowMarket Cap$57.48M
Close$
$0.16
82% downside
Current Fair Value
82% downsideOvervalued by 82% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $57.48 Million |
|---|---|
| Enterprise Value | $61.29 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.45 |
| Beta | 0.7 |
| Outstanding Shares | 187,168,000 |
Return
| Return on Equity | -76.83% |
|---|---|
| Return on Assets | -49.54% |
| Return on Invested Capital | -65.65% |
Valuation & Multiples
| P/E Ratio | -3.27 |
|---|---|
| PEG | -31.31 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 35.88 |
| Enterprise Value to EBIT | -1.86 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$925,000
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$1.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0286▼ 2.92% |
|---|---|
| Total Calls | 1,647,500▼ 55.46% |
| Total Puts | 47,100▼ 77.95% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 29.06%▼ 1.41% |
|---|---|
| Total Invested | $31.41M▼ 48.09% |
| Investors Holding | 77▲ 8.00% |
ESG Score
No data
About Rani Therapeutics Holdings Inc
2,021 employees